Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Blaise

Showing results (61-70 of 510) with videos related to

Pageof 51
Sort By:
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 20, 2012
JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the LiteratureJean El-Cheikh, Sabine Fürst, Francois Casalonga, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.
The European Respiratory Journal|September 3, 2016
Fatal acute respiratory distress syndrome with diffuse alveolar damage: donor lymphocyte infusion imputability?Colombe Saillard, Magali Bisbal, Antoine Sannini, et al.
Bone Marrow Transplantation|July 15, 2021
A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantationSarah Cuvelier, Didier Blaise, Jean-Marie Boher, et al.
Cancers|June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling DonorRaynier Devillier, Boris Calmels, Sophie Guia, et al.
Leukemia & Lymphoma|February 7, 2009
Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALLThomas Prebet, Marie Joelle Mozziconacci, Danielle Sainty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2015
Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcomeCaroline Pical-Izard, Roberto Crocchiolo, Samuel Granjeaud, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Pageof 51

Showing results (61-70 of 510) with videos related to

Sort By:
Pageof 51
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 20, 2012
JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the LiteratureJean El-Cheikh, Sabine Fürst, Francois Casalonga, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.
The European Respiratory Journal|September 3, 2016
Fatal acute respiratory distress syndrome with diffuse alveolar damage: donor lymphocyte infusion imputability?Colombe Saillard, Magali Bisbal, Antoine Sannini, et al.
Bone Marrow Transplantation|July 15, 2021
A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantationSarah Cuvelier, Didier Blaise, Jean-Marie Boher, et al.
Cancers|June 2, 2021
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling DonorRaynier Devillier, Boris Calmels, Sophie Guia, et al.
Leukemia & Lymphoma|February 7, 2009
Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALLThomas Prebet, Marie Joelle Mozziconacci, Danielle Sainty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2015
Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcomeCaroline Pical-Izard, Roberto Crocchiolo, Samuel Granjeaud, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Pageof 51